DLL1 and neuroblastoma: Since DLL1 was identified as the Notch pathway component most expressed in IMR-32 neuroblastoma cells, and since DLL1 increased levels lead to an effective Notch pathway activation, we investigated DLL1 molecular targeting by observing the effects of DLL1 gene silencing via RNA interference technique in neuroblastoma cells.